Evaluate the Efficacy and Safety of Genexol®-PM Compared to Genexol® in Recurrent or Metastatic Breast Cancer
NCT00876486
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
213
Enrollment
INDUSTRY
Sponsor class
Conditions
Breast Cancer
Interventions
DRUG:
Genexol-PM®
DRUG:
Genexol®
Sponsor
Samyang Biopharmaceuticals Corporation